Skip to main content
Log in

Pharmacists have a major role in ADR and medication error monitoring and reporting

  • Drug Reactions and Interactions
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Roberts PI, Wolfson DJ, Booth TG. The role of pharmacists in adverse drug reaction reporting. Drug Saf 1994; 11: 7–11

    Article  PubMed  CAS  Google Scholar 

  2. Kennedy DL, Tanner LA, Barash D, et al. National adverse drug event reporting. Am J Hosp Pharm 1993; 50: 1913–4

    PubMed  CAS  Google Scholar 

  3. Henahan S. Unexpected fate for felbamate. Inpharma 1994; 950: 3

    Google Scholar 

  4. Kessler DA. MED Watch: the new FDA medical products reporting program. Am J Hosp Pharm 1993; 50: 1151–2

    PubMed  CAS  Google Scholar 

  5. British National Formulary 1994; 27: 10

  6. Chen RT, Rastogi SC, Mullen JR, et al. The vaccine adverse event reporting system. Vaccine 1994; 12: 542–50

    Article  PubMed  CAS  Google Scholar 

  7. New Ethicals Catalogue: 8, Apr 1994

  8. American Society of Hospital Pharmacists. ASHP guidelines on adverse drug reaction monitoring and reporting. Am J Hosp Pharm 1989; 46: 336–337

    Google Scholar 

  9. Chrisp P. FDA and ASHP collaborate on serious ADR reporting. Reactions 1993; 456: 4

    Google Scholar 

  10. Stoukides CA, D’Agostino PR, Kaufman MB. Adverse drug reaction surveillance in an emergency room. Am J Hosp Pharm 1993; 50: 712–4

    PubMed  CAS  Google Scholar 

  11. Adamcik BA, Rhodes RS. The pharmacist’s role in rational drug therapy of the aged. Drugs Aging 1993; 3: 481–6

    Article  PubMed  CAS  Google Scholar 

  12. Raymond PM, Robertson MB. Adverse drug reaction reporting in Melbourne teaching hospitals. Aust J Hosp Pharm 1994; 24: 237–42

    Google Scholar 

  13. Hospital pharmacists increase yellow card reporting. Pharm J 1993; 251: 426

  14. Wolfson DJ, Booth TG, Roberts PI. The community pharmacist and adverse drug reaction monitoring (2) An Examination of the potential role in the United Kingdom. Pharm J 1993; 251: 21–4

    Google Scholar 

  15. American Society of Hospital Pharmacists. ASHP guidelines on preventing medication errors in hospitals. Am J Hosp Pharm 1993; 50: 305–14

    Google Scholar 

  16. Mandatory reporting of medication errors that result in death. FDC Reports — The Pink Sheet 1993 Dec 13; 55: T&G5-6

    Google Scholar 

  17. Edgar TA, Lee DS, Cousins DD. Experience with a national medication error reporting program. Am J Hosp Pharm 1994; 51: 1335–8

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pharmacists have a major role in ADR and medication error monitoring and reporting. Drugs Ther. Perspect 5, 10–11 (1995). https://doi.org/10.2165/00042310-199505010-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199505010-00004

Keywords

Navigation